STAT

JUNE 30, 2024

The National Academies of Sciences, Engineering, and Medicine recently released a congressionally mandated report on how to make amyotrophic lateral sclerosis — a brutal, always fatal condition — a “livable” disease in the next 10 years. Essentially, the committee was tasked with delivering a plan for a moonshot. As a health care innovation expert and someone living with ALS, I have to say that the report barely gets off the ground.

338

338

Med Ed 101

JUNE 30, 2024

With this med review, I’m simply looking at a medication list to help formulate ideas to investigate. I’ll focus heavily on my concern for using an NSAID in this patient. NSAID and Heart Failure Concerns There are a few issues of note with the cardiac/heart failure medication regimen. I always have the prescribing cascade in […] The post NSAID Problems – Polypharmacy Case Study appeared first on Med Ed 101.

105

105

STAT

JUNE 30, 2024

A few years ago, the Centers for Medicare and Medicaid Services launched a big experiment. The agency wanted to see if financial incentives and penalties would improve care for people with end-stage kidney disease. So far, it hasn’t worked, a new study finds. The End-Stage Renal Disease Treatment Choices (ETC) model is a historic effort, both because it’s the largest such experiment in the history of American health care and because, unlike previous CMS Innovation Center pilot prog

Hospitals 323

Hospitals 323

Express Pharma

JUNE 30, 2024

In the June 24, 2024 plenary session of Clinical and Laboratory Standards Institute (CLSI), Zaynich (Zidebactam/Cefepime- WCK 5222) has been granted a susceptibility breakpoint of 64 mg/L for around 10 Gram negative pathogens showing high resistance rates. Susceptibility breakpoints guides the doctors about selection of most efficacious antibiotic for treating various infections caused by different pathogens.

97

97

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Drug Patent Watch

JUNE 30, 2024

This chart shows the pharmaceutical companies with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JUNE 30, 2024

After FDA rejection last year, ARS Pharma closes on EU approval for intranasal epinephrine product for anaphylaxis

69

69

pharmacy mentor

JUNE 30, 2024

We can build anything at Pharmacy Mentor. We were very excited about the prospect of launching an aesthetics pharmacy clinic, which we knew would be a market-leading contender About This Pharmacy Skin On You is a B2B aesthetics pharmacy specialising in dermal filler products and delivering top-notch quality aesthetics products to practitioners at very competitive market prices.

Documentation 52

Documentation Vaccines 52

Pharmacy Joe

JUNE 30, 2024

In this episode, I’ll discuss an article about which vasopressor is best in early traumatic brain injury patients. Episode 935: What vasopressor is best to use in traumatic brain injury? Subscribe on iTunes , Android , or Stitcher Patients who have severe traumatic brain injury and develop hypotension that requires vasopressor therapy are already at risk for mortality and poor long term outcomes.

Hospitals 52

Hospitals Inpatient 52

Pharma and Life Sciences Blog

JUNE 30, 2024

GEP ACQUIRES OPUSCAPITA Vijendra Mon, 07/01/2024 - 09:43 Leading Europe-Based E-Invoicing Provider Expands GEP Leadership Across the Nordic Countries Learn More Asset type Newsroom Banner Slide Title GEP Acquires OpusCapita Mobile Banner Image Top Banner

52

52

FDA Law Blog: Biosimilars

JUNE 30, 2024

RAPS Convergence 2024 is set to host a must-attend session on CDRH’s Total Product Life Cycle Advisory Program (TAP), promising attendees an exclusive insight into a pioneering initiative aimed at improving the medical device commercialization landscape. Session Details: A Path to Faster Breakthrough Device Commercialization – CDRH’s Total Product Life Cycle Advisory Program (TAP) Thursday, September 19, 2024, 4:30 PM – 5:30 PM Session Leader: Adrienne Lenz, RAC – Principal Medical Device Regula

52

52

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmacy Times

JUNE 30, 2024

Pharmacists can also play a role in SDOH by replacing drug delivery with something else, such as food or transportation delivery, according to speakers at the ATOPP conference.

55

55

Express Pharma

JUNE 30, 2024

In the United States ( US), a recent initiative by major pharmaceutical companies to cap the cost of asthma inhalers at $35 per month marks a significant development in healthcare affordability and accessibility. Overall, the price cap on asthma inhalers represents a multifaceted victory. For patients, it means improved access to life-saving medications and a reduction in financial stress.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 97